Inactive Instrument

Calendar Biovica International AB (publ) Nasdaq Stockholm

Equities

SE0008613731

Chart calendar Biovica International AB (publ)

8b1d72eb6bc324a.7r4HpC8H09PKi6Dlw7bSY5OZRavAjszq6y5E0Ktmfcw.hcY1l0FK4ZWJytWIruGXL9TJPf2i-o-wrXoyk94MEauCk0KRQU6ZoIvYww~2cae3d1435a60701669f0b54583dd97c

Upcoming events on Biovica International AB (publ)

17/06/2024 Q4 2024 Earnings Release Pre-market
27/08/2024 Q1 2025 Earnings Release (Projected)
12/12/2024 Q2 2025 Earnings Release (Projected)
12/03/2025 Q3 2025 Earnings Release (Projected)
17/06/2025 Q4 2025 Earnings Release (Projected)

Past events on Biovica International AB (publ)

14/03/2024 14:00 Q3 2024 Earnings Call
14/03/2024 07:00 Q3 2024 Earnings Release
06/12/2023 14:00 Carlsquare Investor Day
04/12/2023 San Antonio Breast Cancer Symposium
28/11/2023 14:00 Q2 2024 Earnings Call
28/11/2023 07:00 Q2 2024 Earnings Release
23/11/2023 13:00 Extraordinary Shareholders Meeting
06/09/2023 14:00 Q1 2024 Earnings Call
06/09/2023 07:00 Q1 2024 Earnings Release
05/09/2023 09:00 Annual General Meeting
21/06/2023 14:00 Q4 2023 Earnings Call
20/06/2023 Q4 2023 Earnings Release Pre-market
17/05/2023 12:00 Extraordinary Shareholders Meeting
17/03/2023 14:00 Q3 2023 Earnings Call
16/03/2023 07:20 Q3 2023 Earnings Release
14/12/2022 Interim 2023 Earnings Release Pre-market
08/12/2022 23:00 San Antonio Breast Cancer Symposium - Poster P5-02-27
23/11/2022 Redeye Life Science Day
23/11/2022 05:00 Investor Meeting
21/11/2022 SEB Healthcare Seminar

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
3,01
3,10
-3.06%
1,67
3,00
-44.3%
2,08
3,00
-30.77%
2,05
1,00
104.5%
3,38
5,00
-32.34%

10,0

EBITDA
Million SEK
Released
Forecast
Spread
-18,7
-16,0
-16.86%
-25,6
-32,2
20.23%
-34,0
-34,0
-0.11%
-53,7
-48,0
-11.8%
-102
-86,5
-18.15%

-106

EBIT
Million SEK
Released
Forecast
Spread
-21,7
-20,0
-8.59%
-29,8
-38,0
21.54%
-40,2
-40,0
-0.45%
-60,1
-55,0
-9.27%
-110
-95,0
-16.21%

-116

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-21,5
-19,0
-13.28%
-30,3
-37,7
19.74%
-39,4
-40,0
1.53%
-60,0
-45,5
-31.78%
-111
-95,0
-16.51%

-113

Net income
Million SEK
Released
Forecast
Spread
-21,6
-19,0
-13.45%
-30,3
-28,4
-6.75%
-39,5
-40,0
1.3%
-60,0
-37,1
-61.68%
-110
-94,8
-16.59%

-115

EPS
SEK
Released
Forecast
Spread
-1,23
-1,10
-11.82%
-1,29
-1,60
19.38%
-1,39
-1,42
2.11%
-2,11
-1,48
-42.59%
-3,18
-2,31
-37.95%

-7,42

Announcement Date14/06/1905/06/2017/06/2116/06/2221/06/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million SEK
Released
Forecast
Spread



1,08








0,59
2,00
-70.65%
1,75
2,00
-12.3%
2,56
4,00
-35.93%
1,08
9,00
-88.06%

5,00













EBITDA
Million SEK
Released
Forecast
Spread
-12,9
-11,1
-15.73%
-17,3





-27,2
-20,0
-36.2%
-35,2
-23,0
-53.27%
-29,8
-28,0
-6.58%
-22,9
-26,0
11.84%
-25,5
-27,0
5.44%

-27,7


-17,0


-17,0


-17,0


-13,0

EBIT
Million SEK
Released
Forecast
Spread
-14,4
-11,1
-29.44%
-19,1





-29,3
-22,0
-33.08%
-37,2
-25,0
-49.13%
-32,2
-30,0
-7.31%
-25,3
-29,0
12.7%
-27,8
-28,5
2.29%

-30,4


-19,0


-19,0


-19,0


-16,0

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-14,3
-11,3
-27.31%
-19,1
-14,3
-33.58%



-29,2
-22,0
-32.64%
-37,2
-23,0
-61.75%
-31,9
-25,0
-27.78%
-23,8
-32,0
25.71%
-27,6
-35,0
21.19%

-34,3


-18,6


-18,5


-18,9


-14,9

Net income
Million SEK
Released
Forecast
Spread
-14,3
-11,3
-27.34%
-19,1
-14,3
-33.46%
-23,3


-28,5
-22,0
-29.72%
-37,7
-22,9
-64.29%
-32,3
-24,8
-30.04%
-25,7
-31,7
18.86%
-27,3
-35,1
22.12%

-34,3


-18,6


-18,5


-18,9


-14,9

EPS
SEK
Released
Forecast
Spread
-0,50
-0,31
-60.13%
-0,67
-0,40
-69.17%
-0,81


-0,64
-0,60
-6.67%
-0,81
-0,45
-79.66%
-0,70
-0,30
-133.33%
-0,56
-0,30
-86.67%
-0,44
-0,58
24.63%

-0,40


-0,22


-0,20


-0,19


-0,15

Announcement Date15/03/2216/06/2215/12/2216/03/2321/06/2306/09/2328/11/2314/03/24-----
  1. Stock Market
  2. Equities
  3. BIOVIC B Stock
  4. Stock
  5. Calendar Biovica International AB (publ)